Verantos (https://verantos.com) is the market leader in high-accuracy real-world evidence (RWE) generation. The Verantos RWE platform integrates heterogeneous real-world data sources and generates evidence with the accuracy necessary for regulatory and reimbursement use. The platform leverages data science and artificial intelligence, along with advanced data sources such as electronic health records (EHR), to generate RWE capable of supporting complex clinical studies. Some of the largest biopharma companies in the world are Verantos customers.
We use a heterogeneous AWS-centric tech stack with data processing, AI, workflows, and analytics. Our teams are cross-functional and collaborative, bringing together engineering, product, design, QA, and clinical domain experts to deliver meaningful, real-world impact.
This position is open only to candidates currently based in Pune.
We're looking for a Senior SDET to own end-to-end quality for assigned product features across web apps and backend APIs, with a strong focus on evaluating AI/LLM-powered workflows. You'll build CI-gated automation and evaluation harnesses — covering UI, API, and non-deterministic AI agent behavior — set testing standards for the team, and drive a shift-left quality culture with engineering and product teams.
Why Verantos?
Work at the intersection of cutting-edge tech, complex data, and healthcare research — where your quality engineering directly shapes research-grade evidence.
Competitive salary
Comprehensive medical benefits and work-life balance
Collaboration with healthcare technology visionaries

Verantos is the market leader in high-validity real-world evidence across all therapeutic areas in life sciences. By incorporating robust clinical narrative data, artificial-intelligence technology, and measured validity, Verantos is the first company to generate research-grade evidence at scale. The Verantos RWE platform integrates heterogeneous real-world data sources and generates evidence with the accuracy necessary for market access, medical affairs, and regulatory use.